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Patients with autosomal-dominant polycystic kidney disease
(ADPKD) carry an increased risk of developing intracranial
aneurysms. Bleeding from these sites is a significant
complication with the events reported to cluster in some
families. In this study we determined if individualized risk of
aneurysm rupture can be estimated based on family history
using a Bayesian random effects model. Previously reported
data were used to define distributions and to construct a
model that fit these data. Our results confirm that
intracerebral aneurysm bleeding in ADPKD patients tends to
cluster in families and that basic family history can provide a
simple estimate of family-specific risk.
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Autosomal-dominant polycystic kidney disease (ADPKD)
entails an increased risk of intracranial aneurysms of 4–12%
compared with 1% in the general population. Rupture of
intracranial aneurysms (RICA) accounts for 4–7% of deaths
in the ADPKD population. An important study by Belz et al.1
examined the distribution within ADPKD families of RICA
and concluded that bleeding clustered in some families. On
the basis of such evidence, the current recommendation is to
screen for the presence of intracranial aneurysms on the basis
of family history.2
However, since neither the screening of asymptomatic
patients nor the handling of unruptured aneurysms is
without problems, it was of interest to examine further into
the occurrence of bleedings in the large series reported by
Belz et al.,1 to see if individualized risk estimates of RICA
could be made on the basis of family history.
Combining the possible (22), probable (7), and definite
categories (21), a total of 50 RICA incidences were observed
among 906 ADPKD patients from 199 families, making an
overall frequency of 5.5%. In 170 families there was no RICA,
18 families comprising a total of 129 patients had 1 RICA per
family, giving a frequency of 14%, whereas in 11 families with
2 or more RICA, a total of 32 RICA occurred among 112
patients (29%). On the basis of these results, Belz et al.1
concluded that RICA clustered in families, in the sense that
these data are not compatible with the hypothesis of a
homogeneous level of risk across families.
However, even among this last category with multiple
RICA in a family, the observed frequency varied between
100% (3 RICA in a family size of 3) and 8% (2 RICA in a
family size of 25). Hence, the overall frequency within the
category of multiple RICA families of 29% may not be
sufficiently informative for optimal counselling.
With the aim of estimating the probability for RICA in an
individual patient based on his or her family history (family
size, number of RICA), a random effects Bayesian model was
developed. This has been fitted using the Markov chain
Monte Carlo methods available in the BUGS program, which
is freely available as open source software.3
First, the question of familial clustering is addressed in a
Binomial model with common risk, and then the model
adequacy is assessed by comparing an observed w2-goodness-
of-fit statistic with that calculated on predicted data, which is
known to obey the model. The full code for the model is
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provided below: the goodness-of-fit procedure allows for the
uncertainty in the underlying risk, and makes no large-
sample distributional assumptions. P-value is found to be
0.006, indicating an inhomogeneous distribution of risk
among the families.
When modeling the familial risk, the number r[i] of RICA
within family i is assumed to have a binomial distribution
with p[i] as the probability of RICA in the family, and
ADPKD[i] its given size. p[i], which can be considered as the
underlying risk for each member of the family, is considered
as a random effect drawn from a population distribution
formally expressed as a beta-distribution with parameters a
and b.4 If a new family is observed with r RICA out of n
members with ADPKD, the posterior probability of RICA in
that family also has a beta-distribution with parameters aþ r
and bþ nr. This distribution has mean value (aþ r)/
(aþ bþ n), which is the estimated risk of a further family
member with ADPKD experiencing RICA.
Using this model, parameter estimates were obtained as
shown in Table 1. Note that the Bayesian approach means that
the uncertainty concerning each unknown quantity is repre-
sented by a distribution, which can be summarized by either the
mean and s.d. or median and 2.5 and 97.5% points. The latter is
preferred here due to the skewness of the distributions.
The mean risk in the population of families is estimated to
be 5.3%, which closely matches the overall observed
frequency of 5.5%. Using a computed w2-statistic based on
comparing the fit of predicted data compared to observed
data (see BUGS code), the model fitted well (P¼ 0.57).
The prospective risk can now be estimated for any new
family with r RICA in n members with ADPKD. For example,
suppose r¼ 3 and n¼ 10, then the underlying risk is (aþ 3)/
(aþ bþ 10), which we denote as rr: substituting estimated
values of a and b (say the medians in Table 1) gives an
estimated risk rr¼ (3þ 0.29)/(10þ 0.29þ 5.23)¼ 0.21¼
21%. In fact, a and b are not precisely known, and so there
is uncertainty about this risk: putting a variable rr in the code
as shown below allows us to obtain a 95% confidence interval
for rr of 15–25% for this family of 10 with 3 RICA. Likewise,
one RICA in a family of two suggests an underlying risk of
17% (19–26%) and five RICA in a family of six provides an
estimated risk of 46% (27–61%). Figure 1 shows how the
family size and previous number of bleedings determine the
median prospective risk.
It is observed that the effect of the model is to ‘shrink’ the
estimated risk away from the simple proportion observed in
the family and toward the overall mean: for a¼ 0.29 and
b¼ 5.23, the net effect of the population information is as if
each family already contains 5.23 members with ADPKD of
which 0.29 have RICA. A particularly useful property is that
the model allows prospective assignment of a probability of
RICA for a given patient based on his or her own family
history, provided that the family can be seen as belonging to
the population generating the data analyzed originally by Belz
et al.1 For example, for a large family size of 25 with no
bleedings, the predicted risk for a new individual is 1%
(almost the same as the general population), while in a family
of three with three RICA, a risk of 39% is predicted.
An issue with Bayesian analysis is sensitivity to the choice
of prior distributions: using a uniform prior for a and b
between 0 and 1000 produces an almost unchanged estimate
rr of 20% (95% confidence intervals 13–25%). Hence, the
gain in useful information obtained with the current
formulation comes from the modeled data rather than the
specific prior distributions. A corollary is that if previous
knowledge could be specified with any certainty, further gain
in accuracy should be possible.
The conclusion is that even though the occurrence of RICA
seems to cluster in families, a formulation is possible whereby
the observed interfamilial heterogeneity is in fact captured by
the family history, that is family size and previous number of
RICA. However, the parameter estimates obtained here are
dependent on the specific population reported by Belz et al.,1
and it would be of interest to confirm them if another,
preferably even larger population were available.
Further developments should look into the importance,
ignored here, of multiple bleedings within the same patient as
compared to within a given family. Also, with a larger sample,
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Figure 1 | The median prospective probability of RICA in a
family of given size with previous number of RICA as specified.
For the series of families with two previous RICA, the 2.5 and
97.5% limits are shown.
Table 1 | Estimates of parameters of population distributions
of risks
Mean s.d. Median (2.5%, 97.5%)
a 0.32 0.16 0.29 (0.14, 0.72)
b 5.89 2.90 5.23 (2.28, 13.31)
Mean: a/(a+b) 0.05 0.01 0.05 (0.04, 0.08)
Precision: a+b 6.2 3.1 5.5 (2.4, 14.0)
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the importance of strictly separating between the three
categories of RICA (definite, probable, and possible) could be
investigated. Finally, eventually finding a biological explana-
tion for the interfamilial variability, in terms of, for example,
blood pressure, specific mutation involved, or individual
smoking history could allow for even better prediction.
If appropriate data were available, the simple model used
here might be adapted to these aims.
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Appendix: BUGS code:
#Testing the fit of a homogeneous risk model
for(i in 1:199) {
RICA[i] B dbin(p, ADPKD[i]) # binomial sampling distribution for ith family
}
P B dunif(0,1) # prior distribution of underlying risk
# goodness-of-fit analysis
for(i in 1:199) {
RICA.exp[i] o- ADPKD[i] * P # posterior expected number in family i
RICA.pred[i] B dbin(P,ADPKD[i]) # posterior predictive number in family i
chisq.pred[i] o- pow(RICA.pred[i]- RICA.exp[i], 2)/RICA.exp[i] # contribution to chisq of predicted data obeying
model
chisq.obs[i] o- pow(RICA[i]- RICA.exp[i], 2)/RICA.exp[i] # contribution to chisq of observed data
}
x2.obs o- sum(chisq.obs[]) # goodness-of-fit statistic to uniform distribution
x2.pred o- sum(chisq.pred[]) # variability in predicted rates
Pvalueo-step(x2.pred-x2.obs) # P-value
}
Model {
for(i in 1:199) {
RICA[i] B dbin(p[i], ADPKD[i]) # binomial sampling distribution for ith family
p[i] B dbeta(a,b) # population distribution of underlying risks
}
a o-mean*precision # express a, b as functions of mean and precision (aþ b)
b o-(1-mean)*precision
# prior distributions
mean B dunif(0,1)
precision B dunif(0,1000)
rr o- (aþ 3)/(aþ bþ 10) # risk in family with 3 RICA out of 10 ADPKD
# goodness-of-fit analysis
for(i in 1:199) {
RICA.exp[i] o- ADPKD[i] * p[i] # posterior expected number in family i
RICA.pred[i] B dbin(p[i],ADPKD[i]) # posterior predictive number in family i
chisq.pred[i] o- pow(RICA.pred[i]- RICA.exp[i], 2)/RICA.exp[i] # contribution to chisq of predicted data obeying
model
chisq.obs[i] o- pow(RICA[i]- RICA.exp[i], 2)/RICA.exp[i] # contribution to chisq of observed data
}
x2.obs o- sum(chisq.obs[]) # goodness-of-fit statistic to uniform distribution
x2.pred o- sum(chisq.pred[]) # variability in predicted rates
P-valueo-step(x2.pred-x2.obs) # P-value
}
Program code and data from the paper by Belz et al.1 is available on request from tring@gvdnet.dk
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